Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Invested Capital: 2010-2025

Historic Invested Capital for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to $151.1 million.

  • OptimizeRx's Invested Capital rose 2969.82% to $151.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.1 million, marking a year-over-year increase of 2969.82%. This contributed to the annual value of $151.3 million for FY2024, which is 822.3% down from last year.
  • OptimizeRx's Invested Capital amounted to $151.1 million in Q3 2025, which was up 2969.82% from $148.6 million recorded in Q2 2025.
  • Over the past 5 years, OptimizeRx's Invested Capital peaked at $164.8 million during Q4 2023, and registered a low of $115.8 million during Q2 2023.
  • Over the past 5 years, OptimizeRx's median Invested Capital value was $126.8 million (recorded in 2021), while the average stood at $132.7 million.
  • Per our database at Business Quant, OptimizeRx's Invested Capital soared by 18658.96% in 2021 and then crashed by 1775.51% in 2023.
  • OptimizeRx's Invested Capital (Quarter) stood at $131.4 million in 2021, then dropped by 4.01% to $126.1 million in 2022, then skyrocketed by 30.71% to $164.8 million in 2023, then dropped by 8.22% to $151.3 million in 2024, then fell by 0.16% to $151.1 million in 2025.
  • Its Invested Capital stands at $151.1 million for Q3 2025, versus $148.6 million for Q2 2025 and $150.1 million for Q1 2025.